Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1997-05-05
1999-09-07
LeGuyader, John L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
435 691, 435 694, 4351723, 435 3201, 435325, 570300, 570399, 536 231, 536 235, 536 2351, A61K 3800, C12N 1585, C12N 1516
Patent
active
059487615
ABSTRACT:
Peptides of the formula R.sup.1 -Cys-Phe-Gly-Arg-Arg-Leu-Asp-Arg-Ile-Gly-Ser-Leu-Ser-Gly-Leu-Gly-Cys-R.sup .2
REFERENCES:
patent: 4496544 (1985-01-01), Needleman
patent: 4508712 (1985-04-01), Needleman
patent: 4557864 (1985-12-01), Needleman
patent: 4607023 (1986-08-01), Thibault et al.
patent: 4618600 (1986-10-01), Johnson et al.
patent: 4764504 (1988-08-01), Johnson et al.
patent: 4935492 (1990-06-01), Lewicki et al.
Flynn et al., Biochem. Biophys. Res. Commun. (1983) 117(3):859-865.
Currie et al., Science (1984) 223:67-69.
Kangawa et al., Biochem. Biophys. Res. Commun. (1984) 118(1);131-139.
Kanagawa et al., Biochem. Biophys. Res. Commun. (1984) 119(3):933-940.
Garcia et al., Biochem. Biophys., Res. Commun. (1985) 126(1):178-184.
Katsube et al., Biochem. Biophys. Res. Commun. (1985) 128(1):325-330.
U.S. Patent Application Ser. No. 616,488 (filed Jun. 1, 1984).
U.S. Patent Application Ser. No. 06/870,795 (filed May 6, 1985).
U.S. Patent Application Ser. No. 921,360 (filed Oct. 28, 1986).
U.S. Patent Application Ser. No. 138,893 (filed Dec. 24, 1987.
Sudoh Nature (1988) 332:78-81.
Sudoh et al., Biochem. Biophys. Res. Commun. (1988) 155(2):726-732.
Ueda et al., Biochem. Biophys. Res. Commun. (1988) 155(2):733-739.
Minamino et al., Biochem. Biophys. Res. Commun. (1988) 155(2):740-746.
Minamino et al., Biochem. Biophys. Res. Commun. (1988) 157(1):402-409.
Maekawa et al., Biochem Biophys. Res. Commun. (1988) 157(1):410-416.
Oikawa et al., Biochem. Biophys, Res. Commun. (1985) 132:892-899.
Vlasuk et al., Biochem. Biophys. Res. Commun. (1986) 136:396-403.
Suggs et al., Proc. Natl. Acad. Sci. (1981) 78:6613-6617.
Song et al., FEBS Letters (1988) 232(1):125-129.
Porter et al., J. Biol. Chem. (1989) 264:6689-6692.
Lewicki John
Porter J. Gordon
Scarborough Robert M.
Seilhamer J. Jeffrey
LeGuyader John L.
Scios Inc.
LandOfFree
Recombinant canine brain natriuretic peptide does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant canine brain natriuretic peptide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant canine brain natriuretic peptide will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1804597